Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghulam J Mufti

Showing results (31-40 of 224) with videos related to

Pageof 23
Sort By:
Haematologica|March 15, 2006
Mobilization of hematopoietic progenitors in low-grade myelodysplastic syndromesAleksandar Mijovic, Michel Delforge, Maryam Sekhavat, et al.
British Journal of Haematology|May 28, 2008
Effects on erythropoiesis of alemtuzumab-containing reduced intensity and standard conditioning regimensAleksandar Mijovic, Atiyeh Abdallah, Laurence Pearce, et al.
British Journal of Haematology|April 16, 2003
Precipitation of porphyria cutanea tarda by imatinib mesylate?Aloysius Y L Ho, Allan Deacon, Genevieve Osborne, et al.
Haematologica|June 8, 2006
Life-threatening motor neurotoxicity in association with bortezomibSunil Gupta, Antonio Pagliuca, Steve Devereux, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 12, 2017
The Use of PARP Inhibitors in Cancer Therapy: Use as Adjuvant with Chemotherapy or Radiotherapy, Use as a Single Agent in Susceptible Patients, and Techniques Used to Identify Susceptible PatientsSydney Shall, Terry Gaymes, Farzin Farzaneh, et al.
BMJ Case Reports|October 25, 2019
Intractable pruritus in chronic myelomonocytic leukaemia and myelodysplastic syndromes: a case seriesM Mansour Ceesay, Tanya N Basu, Anthony du Vivier, et al.
Oncogene|December 4, 2003
Constitutive DNA damage is linked to DNA replication abnormalities in Bloom's syndrome cellsFeyruz V Rassool, Philip S North, Ghulam J Mufti, et al.
Seminars in Cancer Biology|February 6, 2004
Targeted therapies in myeloid leukemiaAlison M John, N Shaun B Thomas, Ghulam J Mufti, et al.
British Journal of Haematology|November 20, 2008
Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patientsAzim Mohamedali, Barbara-ann Guinn, Satyajit Sahu, et al.
Cancer Research|January 22, 2017
FLT3 and JAK2 Mutations in Acute Myeloid Leukemia Promote Interchromosomal Homologous Recombination and the Potential for Copy Neutral Loss of HeterozygosityTerry J Gaymes, Azim Mohamedali, Anthony L Eiliazadeh, et al.
Pageof 23

Showing results (31-40 of 224) with videos related to

Sort By:
Pageof 23
Haematologica|March 15, 2006
Mobilization of hematopoietic progenitors in low-grade myelodysplastic syndromesAleksandar Mijovic, Michel Delforge, Maryam Sekhavat, et al.
British Journal of Haematology|May 28, 2008
Effects on erythropoiesis of alemtuzumab-containing reduced intensity and standard conditioning regimensAleksandar Mijovic, Atiyeh Abdallah, Laurence Pearce, et al.
British Journal of Haematology|April 16, 2003
Precipitation of porphyria cutanea tarda by imatinib mesylate?Aloysius Y L Ho, Allan Deacon, Genevieve Osborne, et al.
Haematologica|June 8, 2006
Life-threatening motor neurotoxicity in association with bortezomibSunil Gupta, Antonio Pagliuca, Steve Devereux, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 12, 2017
The Use of PARP Inhibitors in Cancer Therapy: Use as Adjuvant with Chemotherapy or Radiotherapy, Use as a Single Agent in Susceptible Patients, and Techniques Used to Identify Susceptible PatientsSydney Shall, Terry Gaymes, Farzin Farzaneh, et al.
BMJ Case Reports|October 25, 2019
Intractable pruritus in chronic myelomonocytic leukaemia and myelodysplastic syndromes: a case seriesM Mansour Ceesay, Tanya N Basu, Anthony du Vivier, et al.
Oncogene|December 4, 2003
Constitutive DNA damage is linked to DNA replication abnormalities in Bloom's syndrome cellsFeyruz V Rassool, Philip S North, Ghulam J Mufti, et al.
Seminars in Cancer Biology|February 6, 2004
Targeted therapies in myeloid leukemiaAlison M John, N Shaun B Thomas, Ghulam J Mufti, et al.
British Journal of Haematology|November 20, 2008
Serum profiling reveals distinctive proteomic markers in chronic myeloid leukaemia patientsAzim Mohamedali, Barbara-ann Guinn, Satyajit Sahu, et al.
Cancer Research|January 22, 2017
FLT3 and JAK2 Mutations in Acute Myeloid Leukemia Promote Interchromosomal Homologous Recombination and the Potential for Copy Neutral Loss of HeterozygosityTerry J Gaymes, Azim Mohamedali, Anthony L Eiliazadeh, et al.
Pageof 23